Exact Mass: 390.1396204

Exact Mass Matches: 390.1396204

Found 69 metabolites which its exact mass value is equals to given mass value 390.1396204, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Epitalon

4-(2-aminopropanamido)-4-({2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl}carbamoyl)butanoic acid

C14H22N4O9 (390.1386722)

Regadenoson

1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide

C15H18N8O5 (390.14000980000003)

Ala Ala Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carboxypropanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Ala Asp Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]propanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Ala Asp Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C14H22N4O9 (390.1386722)

Ala Asp Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H22N4O9 (390.1386722)

Ala Asp Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]acetamido}pentanedioic acid

C14H22N4O9 (390.1386722)

Ala Glu Asp Gly

(4S)-4-[(2S)-2-aminopropanamido]-4-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Ala Glu Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]acetamido}butanedioic acid

C14H22N4O9 (390.1386722)

Ala Gly Asp Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carboxypropanamido]pentanedioic acid

C14H22N4O9 (390.1386722)

Ala Gly Glu Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carboxybutanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Asp Ala Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]propanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Asp Ala Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C14H22N4O9 (390.1386722)

Asp Ala Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H22N4O9 (390.1386722)

Asp Ala Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]acetamido}pentanedioic acid

C14H22N4O9 (390.1386722)

Asp Asp Ala Ala

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C14H22N4O9 (390.1386722)

Asp Glu Ala Gly

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Asp Glu Gly Ala

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H22N4O9 (390.1386722)

Asp Gly Ala Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}propanamido]pentanedioic acid

C14H22N4O9 (390.1386722)

Asp Gly Glu Ala

(4S)-4-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Glu Ala Asp Gly

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Glu Ala Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]propanamido]acetamido}butanedioic acid

C14H22N4O9 (390.1386722)

Glu Asp Ala Gly

(4S)-4-amino-4-{[(1S)-2-carboxy-1-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Glu Asp Gly Ala

(4S)-4-amino-4-{[(1S)-2-carboxy-1-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Glu Glu Gly Gly

(4S)-4-[(2S)-2-amino-4-carboxybutanamido]-4-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)butanoic acid

C14H22N4O9 (390.1386722)

Glu Gly Ala Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}propanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Glu Gly Asp Ala

(4S)-4-amino-4-[({[(1S)-2-carboxy-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C14H22N4O9 (390.1386722)

Glu Gly Glu Gly

(4S)-4-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H22N4O9 (390.1386722)

Glu Gly Gly Glu

(2S)-2-(2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}acetamido)pentanedioic acid

C14H22N4O9 (390.1386722)

Gly Ala Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carboxypropanamido]pentanedioic acid

C14H22N4O9 (390.1386722)

Gly Ala Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carboxybutanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Gly Asp Ala Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]propanamido]pentanedioic acid

C14H22N4O9 (390.1386722)

Gly Asp Glu Ala

(4S)-4-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Gly Glu Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]propanamido]butanedioic acid

C14H22N4O9 (390.1386722)

Gly Glu Asp Ala

(4S)-4-(2-aminoacetamido)-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C14H22N4O9 (390.1386722)

Gly Glu Glu Gly

(4S)-4-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C14H22N4O9 (390.1386722)

Gly Glu Gly Glu

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]acetamido}pentanedioic acid

C14H22N4O9 (390.1386722)

Gly Gly Glu Glu

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carboxybutanamido]pentanedioic acid

C14H22N4O9 (390.1386722)

Glu Gln Asp

C14H22N4O9 (390.1386722)

Gln Asp Glu

C14H22N4O9 (390.1386722)

Regadenoson

C15H18N8O5 (390.14000980000003)

D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C - Cardiovascular system > C01 - Cardiac therapy Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS[1][2]. Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS[1][2].

1-{[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl}piperazine dihydrochloride

C19H29Cl3N2 (390.1396204)

Epithalon

C14H22N4O9 (390.1386722)

Epitalon is an anti-aging agent and a telomerase activator. Epitalon has an inhibitory effect of the on the development of spontaneous tumors in mice, has geroprotective actions and intranasal administration increases neuronal activity. Epitalon can be used for cancer, old age and Retinitis Pigmentosa[1].